clinical trials

BioXcel Therapeutics, Inc. is a biopharmaceutical company traded on Nasdaq under the symbol BTAI. It describes itself as pursuing AI-based Drug Re-innovation and maintains a pipeline and products, including IGALMI, a registered trademark of BioXcel Therapeutics, Inc. The company has an affiliate, OnkosXcel Therapeutics, and conducts clinical research including the SERENITY At-Home Phase 3 Trial for agitation associated with bipolar disorders or schizophrenia. It is headquartered at 555 Long Wharf Drive, 12th Floor, New Haven, CT 06511.

AI-based drug re-innovationclinical research

The Black Hills Regional Eye Institute is an ophthalmology practice in Rapid City, South Dakota, whose mission is to provide comprehensive eye care of the highest quality in an efficient and innovative manner and to continually improve that care through education and research. Its physicians and staff provide diagnosis, treatment, consultation, surgery, research, and education, from general vision screening to laser eye surgery.

blepharoplastycataract surgerycornea treatmentdry eye treatmentglaucoma treatmentlaser surgeryLASIKMohs surgeryoculoplastic surgeryphotodynamic therapyPRKretina treatment

Brain Matters Research is a privately owned and operated clinical trial site in Delray Beach and Stuart, Florida, recognized as a Center of Excellence in Alzheimer's disease, Mild Cognitive Impairment, Age Related Cognitive Decline, and Cognitive Enhancement. It conducts clinical research with new and existing drugs and typically has 18-20 ongoing trials, ranging from prevention trials to trials for current Alzheimer's sufferers and other dementias.

clinical researchECGinfusionmemory assessmentmemory screeningon-site laboratory testingphlebotomypsychometric/neuropsychological testing

BridgeBio Pharma, Inc. is a biotechnology company focused on developing medicines for genetic conditions. It operates a decentralized hub-and-spoke model called The Bridge Way, in which autonomous affiliate teams focus on specific conditions or drug candidates while a central hub provides clinical, regulatory, and commercial capabilities. Its pipeline includes approved products Attruby (acoramidis) and NULIBRY (fosdenopterin), plus investigational candidates such as encaleret, BBP-418, and infigratinib.

academic research partnershipsclinical developmentcommercial capabilitiesdrug developmentregulatory capabilities

Britecyte is a regenerative medicine company based in Frederick, MD, founded in 2020. It develops Biorestoration therapies using a proprietary adipose tissue technology platform that preserves native adipose architecture while removing immunogenic components, enabling allogeneic transplantation. Its commercial products include Liposana for foot fat pad loss and Lipoderma for aesthetic soft tissue restoration.

adipose tissue processing technologyallogeneic transplantationregenerative medicine research

ADC MidWest (Anal Dysplasia Clinic MidWest) is an anal cancer prevention practice in Chicago, Illinois, specializing in the evaluation and treatment of HPV-related anal diseases. It is a site for the AIDS Malignancy Consortium (AMC), part of the National Cancer Institute, and became an ANCHOR Study site in January 2015. The practice has provided care for over 15 years under Dr. Gary Bucher.

anal Botox treatmentanal precancer screeningHPV vaccinationHRA-guided anal precancer treatmentHRA (high-resolution anoscopy)

Camellix, LLC develops and markets products based on patented green tea/EGCG technologies, including EC16 nanotechnology, for dry mouth relief, herpes treatment, and prevention of viral infection. It is associated with the Dental College of Georgia at Augusta University, and its brands include MighTeaFlow dry mouth relief, AverTeaX cold sore treatment, ProtecTeaV viral prevention, and ReviTeaLize hair care, manufactured in the USA.

EC16 nanotechnologygreen tea/EGCG technology research and developmentproduct development and manufacturing

Canary Oncoceutics is a cancer diagnostics company developing genomic profiling tests for early detection and personalized treatment guidance. Its tests are CLIA-certified and CAP-Accredited for solid and liquid tumors, analyzing genes to identify mutations for targeted therapy, immunotherapy, and cancer risk assessment. The company also pursues research collaborations and companion diagnostic development.

AI-powered insightscompanion diagnostic developmentcomprehensive gene profilinggenomic profilingliquid biopsy / ctDNA analysis

Candel Therapeutics is a clinical-stage biotech company developing off-the-shelf viral immunotherapies for solid tumors. Its lead therapy, aglatimagene besadenovec (CAN-2409), is an adenoviral gene construct encoding HSV-thymidine kinase that triggers immunogenic cell death and CD8+ T cell-mediated anti-tumor immunity. The company also develops linoserpaturev, a replication-competent HSV engineered for selective killing of cancer cells. Phase 3 data in prostate cancer and active trials in lung and brain cancer are cited.

gene therapyoncolytic virus engineeringviral immunotherapy

CardResearch is a Brazilian clinical research group based in Belo Horizonte, Minas Gerais. It conducts scientific research and clinical trials, including the TOGETHER Trial, a multi-center, adaptive, randomized platform trial evaluating repurposed medicines in outpatients with early COVID-19 at high risk for complications. The TOGETHER Trial group received the David Sackett Award, described as the most important award in evidence-based medicine, as the most important research group of 2021.

multi-center adaptive randomized platform trialsscientific research

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its lead small-molecule drug candidate, CardiolRx™, modulates inflammasome pathway activation and is being evaluated in clinical trials for pericarditis, myocarditis, and heart failure. The company is also developing CRD-38, a novel subcutaneously administered drug formulation intended for the treatment of inflammatory heart disease.

clinical developmentdrug developmentresearch and development

Cardio Metabolic Institute (CMI) is a multi-specialty medical group in New Jersey with locations in Somerset, Perth Amboy, Edison, and Monroe Township. Its team of board-certified cardiologists, internal medicine and pain management physicians, physical therapists, exercise physiologists, dietitians, and health coaches takes a multidisciplinary, holistic approach to heart disease prevention and treatment, nutritional counseling, weight loss, primary care, and interventional pain management.

ambulatory blood pressure monitoringangioplastyechocardiographyelectrocardiography (ECG/EKG)endovascular aneurysm repair (EVAR)endovenous laser therapy (EVLT)heart valve repair/replacementHolter monitoringon-site diagnostic testing for heart and vascular diseasepercutaneous coronary intervention (PCI)stent placementstress testing

Between Life and Death A book by Dr. Kashyap Patel It is a collection of real-life stories of those ordinary human beings who put up extraordinary bravery in the face of certain death. Read more We believe that service to humanity is a service to God. We are a Patient-Centered Specialty Practice(PCSP) recognized by NCQA We are an Oncology Care Model(OCM) Practice Targeted Oncology Adds Carolina Blood and Cancer Care to Its Strategic Alliance Partnership Program We at the Carolina Blood and Cancer Care Associates believe that each individual has been granted with healing power within themselves. We as physicians trained in the field of cancer medicine, facilitate the healing process with the help of the state of the art tools using chemotherapy, biotherapy, immunotherapy and radiotherapy. We shall constantly endeavor to use all possible avenues to promote both physical and emotional well.

biotherapychemotherapyCT scanningimmunotherapyinfusion therapyradiotherapy

Central States Research is a dedicated clinical research site in Tulsa, Oklahoma, offering cutting-edge treatments in multiple therapeutic areas. It partners with pharmaceutical companies and local physicians to conduct clinical trials, helping qualified patients access the latest medications before FDA approval. The company emphasizes patient relationships and safety, and trial services are funded by pharmaceutical companies.

clinical researchpatient screening and enrollment

Charter Research partners with patient volunteers to conduct clinical trials of new potential treatments. At its research centers, the company conducts clinical trials to test innovative new treatments, with a focus on disease treatment studies, symptom treatment studies, and prevention studies. It has locations in Chicago, IL, Orlando, FL, and The Villages, FL.

clinical researchpatient prescreening

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure. It develops regenerative peptide drugs, led by TP508 (Rusalatide acetate, Chrysalin), to restore vascular function and activate stem cells. Incorporated in Delaware in 2012, it is based in Galveston, Texas.

drug formulation/CMC developmentpeptide drug developmentpreclinical studies

Circle Clinical Research is a clinical trial site based in Sioux Falls, South Dakota, with additional locations in Sioux Falls and Pierre, SD. It connects all communities to clinical trials, especially historically underrepresented groups, and provides free clinical trial infrastructure and support to community physicians, private practices and clinics. It was founded by CEO Lynn Bartholow.

eSource and eRegulatoryfast study startupparticipant networkquality assurance

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products. LYMPHIR (denileukin diftitox-cxdl), a targeted immune therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL), is approved by the FDA.

development and commercialization of critical care productsdrug developmentmanufacturingstem cell therapy

Clarametyx Biosciences is a clinical stage biopharmaceutical company committed to developing novel immune-enabling therapies for serious or difficult-to-treat respiratory diseases. Its approach targets bacterial biofilms, the driver of many progressive lung diseases, aiming to modify the course of chronic respiratory disease rather than just manage symptoms. Its investigational agent is CMTX-101, evaluated in a Phase 2a study in cystic fibrosis.

clinical developmenttherapeutic development

ClarityTek is a research and development company headquartered in Minneapolis, USA that develops non-invasive Virtual Reality Cognitive Therapy (VRCT) for conditions including Alzheimer's, Stroke, Traumatic Brain Injury, Cancer Related Cognitive Impairment, face blindness, ADHD, and lung disease. It is a 2022 NIH-NIA Awardee (R43AG076169) and a NIH-NIDA Startup Challenge Round 1 Winner. The company also creates Virtual Reality Apps, Mobile and Neuro Feedback Medical Apps.

design and testingdigital therapy designresearch and developmentsoftware developmentVirtual Reality Cognitive Therapy development

Clear Scientific is a biopharmaceutical company pioneering novel therapies for life-threatening and debilitating conditions caused by an excess of harmful substances in the body. Its lead candidate CS-1103 is a small-molecule sequestrant that binds and inactivates fentanyl, accelerating its removal from the body, and has shown positive Phase 2 results. Preclinical research also explores CS-1103 for methamphetamine overdose.

biopharmaceutical researchpreclinical studies

Clinical Associates celebrates our 34th Anniversary!1992-2026 telehealth Virtual check-in ATTENTION: Credit card on file is required for all telehealth appointments.Interested in participating in clinical trials? Clinical Trials Police & Public Safety Evaluations & Treatment Welcome We are pleased to have the opportunity to serve you and hope that this website will provide information helpful in making an informed decision concerning our services. For any questions that you may have, please contact the office at (913) 677-3553.Our clinic offers both in-person and telehealth visits. If you have a scheduled appointment, or would like to become a new patient, please contact our office to setup your tele-health appointment. Documents available in the office represent the most current versions. Effort is made to keep the website current but any discrepancy between information presented here.

psychological evaluationspsychotherapySubstance abuse counselingtelehealth

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing oral medications designed to treat neurodegenerative disorders. Its lead candidate, zervimesine (CT1812), is an investigational first-in-class small-molecule oral therapy designed to protect brain synapses by blocking toxic protein oligomers, and is being investigated for dementia with Lewy bodies (DLB) and Alzheimer's disease.

drug developmentmanufacturing oversightprocess developmentquality control

Coherus Oncology is a commercial-stage company focused on developing and commercializing a diversified portfolio of next-generation immuno-oncology therapies that target the tumor microenvironment and potentially extend patient survival across tumor types. Its FDA-approved therapy LOQTORZI (toripalimab-tpzi) treats recurrent, locally advanced or metastatic nasopharyngeal carcinoma in combination with chemotherapy or as a single agent. The company has multiple clinical-stage immuno-oncology candidates and ongoing clinical trials across cancer indications.

commercializationimmuno-oncology drug developmentmanufacturing and supply chain managementmarketing